Important notice

The information on this page is intended for use only by knowledgeable and experienced professionals working in the healthcare and medical industry. By continuing, you automatically confirm that you are a professional working for a healthcare provider in a European country.

Yes No
18F-Fluoromethycholine

18F-Fluoromethycholine

Description

It is used as a diagnostic radiopharmaceutical in oncology for the re-staging of patients with prostate cancer, the detection of locoregional recurrence of prostate cancer and the detection of bone metastases from prostate cancer. It is also used in differential diagnosis between brain metastases, gliomas, and benign brain lesions. Additionally, it is used to the imaging of hepatocellular carcinoma (HCC), both in patients at the initial diagnosis of HCC and in patients with HCC recurrence.

Specifications

Active Substance

[18F]Fluoromethylcholine

Pharmacotherapeutic group

Other diagnostic radiopharmaceutical for tumor detection

Active Form / Packaging

Solution for Injection 44 – 6900 MBq/mL

Downloadable File